Scorpius BioManufacturing Selected as U.S. Manufacturing Partner for Tivic’s Lead Biologic
Scorpius BioManufacturing, a leading U.S.-based CDMO, has been chosen by Tivic Health® Systems to complete GMP manufacturing validation for Entolimod™, the company’s lead candidate for treating Acute Radiation Syndrome (ARS). This milestone supports Tivic’s preparation to file a Biologics License Application (BLA) with the FDA. As the primary U.S. manufacturer, Scorpius will leverage its scientific and technical capabilities to validate the commercial production process—underscoring its growing role as a trusted partner in bringing novel therapeutics to market.
Scorpius BioManufacturing Selected as U.S. Manufacturing Partner for Tivic’s Lead Biologic